• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BDX
Click for more information
1.08% 9.4¢

BCAL DIAGNOSTICS LIMITED - Charts / Financials

Market Cap $23.71M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on... BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on improving health outcomes for women. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. It developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The Company has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 11.55am 10/05/2024 (20 minute delay) ?
Day
Open 9.3¢   Day High 9.9¢   Day Low 9.3¢
Daily Volume 43046
Bids   Sellers
Number Price Volume   Number Price Volume
1 9.3¢ 172   1 10.5¢ 95238

Directors & Senior Management

Ms. Jayne Shaw Executive Chairman of the Board
Mr. Shane Ryan Chief Executive Officer
Mr. Guy Adrian Robertson Chief Financial Officer, Company Secretary
Dr. Amani Batarseh Chief Scientific Officer
Mr. David Gregory Darling Non-Executive Director
Dr. John Hurrell Non-Executive Director
Mr. Ronald Phillips Non-Executive Director
Mr. Mark D.I. Burrows Non-Executive Independent Director
Mr. Jonathan Alfred Trollip Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
9.4¢ 		Change
0.001(1.08%) 		Mkt cap ! $23.71M
Open High Low Value Volume
9.3¢ 9.9¢ 9.3¢ $4.177K 43.04K

Buyers (Bids)

No. Vol. Price($)
1 172 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 95238 1
View Market Depth
Last trade - 12.45pm 10/05/2024 (20 minute delay) ?
Last
9.8¢ 		  Change
0.001 ( 6.52 %)
Open High Low Volume
9.1¢ 9.8¢ 9.1¢ 36921
Last updated 11.55am 10/05/2024 ?

Top Stories

Mantle Minerals to kick off drilling at Mt Berghaus in WA

Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.